Citation Tools
PDFClinical/translational cancer immunotherapy
Original research
First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE2-receptor E-type 4 (EP4), in patients with advanced cancers
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE2-receptor E-type 4 (EP4), in patients with advanced cancers